AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimavi 2mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Avita Laboratories Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimavi 2mg/500mg Tablet

Diabexe 2mg/500mg tablets are classified as antidiabetic medications, combining two active agents to manage type 2 diabetes in adults. This dual-action formulation helps regulate blood glucose. Diabexe 2mg/500mg tablets should be administered with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical consultation risks elevated glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan, including dietary adjustments, regular exercise, and weight management as directed by your healthcare provider. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms such as sweating, lightheadedness, headache, and tremors. Regular meals and readily available fast-acting glucose sources (e.g., sugary snacks, fruit juice) are essential to mitigate this risk. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating women must seek medical counsel before use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to track blood cell counts and liver function.

Primary Ingredients of Glimavi 2mg/500mg Tablet

The provided text is "undefined," which contains no information to rephrase. Therefore, no rewritten text can be provided.

Uses of Glimavi 2mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Glimavi 2mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Glimavi 2mg/500mg Tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.

Common Side effects of Glimavi 2mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimavi 2mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or breaking it. The Glimavi 2mg/500mg tablet should be administered with a meal.

How Glimavi 2mg/500mg Tablet works:

Glimepiride and Metformin 2mg/500mg (Glimavi) tablets combine two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimavi 2mg/500mg tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimavi 2mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible risks prior to prescription. Seek medical advice before using this medication.

Breast feedingBreast feedingUNSAFE

Lactation and the use of Glimavi 2mg/500mg tablets are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Glimavi 2mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Glimavi 2mg/500mg tablet use. Physician consultation is necessary. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimavi 2mg/500mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate hepatic dysfunction, initiation should be at a reduced dosage; however, Glimavi 2mg/500mg tablets are contraindicated in patients with severe liver disease.

What if you forget to take Glimavi 2mg/500mg Tablet :

Should you forget a Glimavi 2mg/500mg Tablet dose, take it immediately. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimavi 2mg/500mg Tablet

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Glimavi 2mg/500mg Tablet

Maintain this medication within its original, sealed container. Follow the storage guidelines provided on the packaging. Discard any remaining medicine. Ensure its inaccessibility to children, animals, and other individuals.
Glimavi 2mg/500mg Tablets can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare but potentially dangerous side effect is more likely in individuals with impaired kidney function, the elderly, or those who consume significant alcohol. Symptoms may involve muscle aches or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or bradycardia. Should these symptoms appear, discontinue Glimavi 2mg/500mg Tablets and seek immediate medical attention.
Glimepiride/Metformin 2mg/500mg tablets combine two medications to manage type 2 diabetes mellitus. This treatment improves blood sugar control in adults when coupled with a healthy diet and physical activity. Glimepiride stimulates insulin secretion from the pancreas, reducing blood glucose. Metformin decreases hepatic glucose production and enhances insulin responsiveness. This dual-therapy regimen is unsuitable for type 1 diabetes.
Glimavi 2mg/500mg tablets may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, and headache. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged treatment may result in vitamin B12 deficiency.
Glimavi 2mg/500mg Tablet's prolonged administration can indeed lead to Vitamin B12 deficiency by hindering its gastric absorption. This deficiency, if left unaddressed, might result in anemia, neurological complications such as paresthesia in the extremities, weakness, urinary dysfunction, cognitive impairment, and ataxia. Prophylactic annual supplementation with exogenous Vitamin B12 is recommended by some studies to mitigate these risks.
Indeed, Glimavi 2mg/500mg Tablets can induce hypoglycemia. Low blood sugar may manifest as nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carry a readily available fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimavi 2mg/500mg tablets and alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and heighten the risk of lactic acidosis.
Glimavi 2mg/500mg Tablet
53
MRP 64
17% off